A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 128 participants.
Also called NCT03848793
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 128 participants
- Registry
-
NCT03848793
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03848793. Randomized; quadruple masking; primary purpose treatment. Start 2019-03-06 (actual); primary completion 2020-06-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- HS-20004
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct03848793- Content hash
ba824af4ad6cf59f55cfe99425aa27c37f11187710bcd053512d8597d2fddba6